Login to Your Account



Nektar Halts Partnership Talks Over Exubera Cancer Concerns

By Donna Young


Thursday, April 10, 2008
Nektar Therapeutics Inc. said it will cease all spending and partnership talks for Exubera after a new analysis of clinical trial data revealed an increased risk of lung cancer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription